DR PRATIM SENGUPTA

Nephro Care India reports 86.07 per cent jump in PAT at Rs 4.41 crore for FY 23-24

​ Revenue from operations on a standalone basis increased by 59.33 per cent at Rs 27.23 crore during the financial year 2023-24, up from Rs 17.09 crore last year. The company’s operating profit (EBITDA) surged nearly 99.41 per cent to Rs 6.84 crore during FY24 (April – March 2024) as against Rs 3.43 crore registered during FY23. It reported an EBITDA margin of 25.10 per cent in FY24, an improvement of 505 basis points from 20.05 per cent over the previous year.